Comparison of MELD and Child-Pugh Scores to Predict Survival after Chemoembolization for Hepatocellular Carcinoma

• Published in: Journal of vascular and interventional radiology Vol. 15; no. 11; pp. 1209 - 1218
• Main Authors: Brown, Daniel B., Fundakowski, Christopher E., Lisker-Melman, Mauricio, Crippin, Jeffrey S., Pilgram, Thomas K., Chapman, William, Darcy, Michael D.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.2004
• Subjects: Albumins - analysis; Antibiotics, Antineoplastic - administration & dosage; Antibiotics, Antineoplastic - therapeutic use; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - therapeutic use; Bilirubin - blood; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - therapy; Chemoembolization, Therapeutic - methods; Cisplatin - administration & dosage; Cisplatin - therapeutic use; Doxorubicin - administration & dosage; Doxorubicin - therapeutic use; Humans; Liver Neoplasms - mortality; Liver Neoplasms - therapy; Mitomycin - administration & dosage; Mitomycin - therapeutic use; Predictive Value of Tests; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; AST; MELD; TACE; HCC; INR; CLIP; TIPS

To compare the value of the Child-Pugh and Model for End-stage Liver Disease (MELD) scores to predict patient survival rates after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Eighty-seven patients underwent 169 TACE sessions. Child-Pugh and MELD values were calculated...